ACE inhibitor cilazapril: its place in cardiovascular diseases treatment

ACE inhibitor cilazapril: its place in cardiovascular diseases treatment

ACE inhibitors play an important role in treatment of arterial hypertension, chronic heart failure, as well as in prevention of stroke and coronary heart disease complications. A new ACE inhibitor, cylasapril, is characterized by high antihypertensive efficacy and good tolerability. Cilasapril demon...

Full description

Bibliographic Details
Main Author:	G. A. Baryshnikova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2005-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ace inhibitors cilasapril arterial hypertension initiative program
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/996

Similar Items

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

Clinical, cardio-hemodynamical, and respiratory effects of ACE inhibitor cilazapril in patients with arterial hypertension and chronic obstructive pulmonary disease
by: L. I. Olbynskaya, et al.
Published: (2005-02-01)

ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)

ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.
by: Lyudmila Gennadievna Ratova, et al.
Published: (2009-09-01)

Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons
by: Yu. M. Lopatin
Published: (2006-06-01)

ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION
by: M. P. Metrova, et al.
Published: (2016-01-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach
by: Seema Bawa, et al.
Published: (2019-03-01)

Modern possibilities of hypertension drug therapy. Candesartan and its place in the therapy
by: O L Barbarash, et al.
Published: (2013-12-01)

COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016-01-01)

Use of ACE-inhibitors in Serbia in 2009 and 2010
by: Perić Dajana M., et al.
Published: (2014-01-01)

Comparative efficacy of ace inhibitor spirapril in hypertensive patients from various age groups
by: L. A. Sokolova, et al.
Published: (2006-06-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Dose response of ACE inhibitors: implications of the SECURE trial
by: Lonn Eva
Published: (2001-07-01)

ACE inhibitor fosinopril in the treatment of hypertension: potential benefits
by: AO Konradi
Published: (2014-12-01)

In-silico study of the Effectiveness of Allium sativum L. extract as an Angiotensin-Converting Enzyme (ACE) Inhibitor in Hypertension
by: Agus Limanto, et al.
Published: (2023-09-01)

CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES
by: N. A. Dzhaiani
Published: (2015-09-01)

ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis
by: Lukas Bütikofer, et al.
Published: (2020-03-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

Cough Syncope due to ACE Inhibitor
by: Filiz Koc, et al.
Published: (2015-09-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

ACE inhibitor lisinopril influence on left ventricular diastolic dysfunction and endothelial response in hypertensive patients with or without chronic heart failure
by: A. D. Kuimov, et al.
Published: (2004-06-01)

Ramipril - angiotensin converting enzyme ingibitor with a wide spectrum of therapeutic action
by: Dmitriy Vladimirovich Preobrazhenskiy,, et al.
Published: (2009-03-01)

The role of fosinopril in the treatment and prevention of cardiovascular diseases
by: G. A. Baryshnikova
Published: (2015-12-01)

Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

ACE inhibitors in the treatment of ischemicheart disease and prevention of its complications (review)
by: V V Schekotov
Published: (2004-03-01)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
by: Sandeep Bansal, et al.
Published: (2020-05-01)

ACE inhibitors as a risk factor for hypoglycemia
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011-12-01)

Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination
by: M. V. Leonova
Published: (1970-01-01)

Age Dependendent Efficacy of Ace Inhibitors Among Chinese Cardiovascular Patients During Hospitalization Phase
by: Tabish Hussain
Published: (2011-01-01)

Age Dependendent Efficacy of Ace Inhibitors Among Chinese Cardiovascular Patients During Hospitalization Phase
by: Tabish Hussain
Published: (2011-01-01)

Selection of an ACE inhibitor in clinical practice
by: OD Ostroumova, et al.
Published: (2014-12-01)

COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS
by: T. D. Kaplanov, et al.
Published: (2015-12-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION
by: S. A. Berns, et al.
Published: (2017-12-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)